FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020242208> ?p ?o ?g. }

• W3020242208 endingPage "42" @default.
• W3020242208 startingPage "38" @default.
• W3020242208 abstract "Aim: The purpose of the study was to review the efficacy, safety, and tolerability of botulinum toxin A (BTX-A) as a prophylactic treatment in adults with chronic daily headache (CDH). Material and methods: The research participated in 100 patients with CDH comparing two groups of patients. Group I, 54 patients (31 women and 23 men) treated by BTX-A and group II, 46 patients (27 women and 21 men) treated with the classical method, with an average age of 35 ± 9 years. The patient’s condition in group I was assessed on the third day, on the 7th day and the 15th day after the BTX-A injection and assessed every 15 days for 3 months, in group II the patients were evaluated every 15 days. Results: After 3 months headache severity in group I: 2 (3,7%) patients had no changes, 7 (12,9%) patients with less than 50 percent reduction in pain, 23 (42,6%) reported 70 to 95 percent pain relief, and 22 (40,8%) had complete relief. Group II: 12 (26,1%) patients had no changes, 16 (34,8%) patients with less than 50 percent reduction in pain, 10 (21,7%) reported 70 to 95 percent pain relief, and 8 (17,4%) had complete relief. The mean change from baseline frequency of headaches ranged from 3 ± 1 headaches per 30‐day periods in-group I and 7 ± 2 headaches in group II. The patient’s in-group I used painkillers for an acute headache 4 ± 1 day, compared to 10 ± 2 days for the group II per 30-day period. Conclusion: In this study, BTX-A injections are safe, well-tolerated, not any treatment-related serious adverse events reported. BTX-A injections recommended optimizing clinical outcomes for patients with CDH without using other prophylactic medications. Although, further observations are needed." @default.
• W3020242208 created "2020-05-01" @default.
• W3020242208 creator A5040384952 @default.
• W3020242208 creator A5054848602 @default.
• W3020242208 date "2020-05-02" @default.
• W3020242208 modified "2023-09-30" @default.
• W3020242208 title "Management of Chronic Daily Headache with Focus on Botulinum Toxin Type A" @default.
• W3020242208 cites W1967364781 @default.
• W3020242208 cites W2005239637 @default.
• W3020242208 cites W2006048052 @default.
• W3020242208 cites W2008201027 @default.
• W3020242208 cites W2022503165 @default.
• W3020242208 cites W2038833296 @default.
• W3020242208 cites W2043661731 @default.
• W3020242208 cites W2061458317 @default.
• W3020242208 cites W2064501211 @default.
• W3020242208 cites W2132968602 @default.
• W3020242208 cites W2160202859 @default.
• W3020242208 cites W2769724041 @default.
• W3020242208 doi "https://doi.org/10.36502/2020/hcr.6159" @default.
• W3020242208 hasPublicationYear "2020" @default.
• W3020242208 type Work @default.
• W3020242208 sameAs 3020242208 @default.
• W3020242208 citedByCount "0" @default.
• W3020242208 crossrefType "journal-article" @default.
• W3020242208 hasAuthorship W3020242208A5040384952 @default.
• W3020242208 hasAuthorship W3020242208A5054848602 @default.
• W3020242208 hasBestOaLocation W30202422081 @default.
• W3020242208 hasConcept C126322002 @default.
• W3020242208 hasConcept C141071460 @default.
• W3020242208 hasConcept C1862650 @default.
• W3020242208 hasConcept C197934379 @default.
• W3020242208 hasConcept C2777478456 @default.
• W3020242208 hasConcept C2778375690 @default.
• W3020242208 hasConcept C2780966972 @default.
• W3020242208 hasConcept C2781118164 @default.
• W3020242208 hasConcept C2993247534 @default.
• W3020242208 hasConcept C3020646304 @default.
• W3020242208 hasConcept C42219234 @default.
• W3020242208 hasConcept C71924100 @default.
• W3020242208 hasConceptScore W3020242208C126322002 @default.
• W3020242208 hasConceptScore W3020242208C141071460 @default.
• W3020242208 hasConceptScore W3020242208C1862650 @default.
• W3020242208 hasConceptScore W3020242208C197934379 @default.
• W3020242208 hasConceptScore W3020242208C2777478456 @default.
• W3020242208 hasConceptScore W3020242208C2778375690 @default.
• W3020242208 hasConceptScore W3020242208C2780966972 @default.
• W3020242208 hasConceptScore W3020242208C2781118164 @default.
• W3020242208 hasConceptScore W3020242208C2993247534 @default.
• W3020242208 hasConceptScore W3020242208C3020646304 @default.
• W3020242208 hasConceptScore W3020242208C42219234 @default.
• W3020242208 hasConceptScore W3020242208C71924100 @default.
• W3020242208 hasIssue "2" @default.
• W3020242208 hasLocation W30202422081 @default.
• W3020242208 hasOpenAccess W3020242208 @default.
• W3020242208 hasPrimaryLocation W30202422081 @default.
• W3020242208 hasRelatedWork W2046551008 @default.
• W3020242208 hasRelatedWork W2055864514 @default.
• W3020242208 hasRelatedWork W2060316636 @default.
• W3020242208 hasRelatedWork W2113717442 @default.
• W3020242208 hasRelatedWork W2165930614 @default.
• W3020242208 hasRelatedWork W2746435024 @default.
• W3020242208 hasRelatedWork W3020242208 @default.
• W3020242208 hasRelatedWork W3022388632 @default.
• W3020242208 hasRelatedWork W4285278682 @default.
• W3020242208 hasRelatedWork W2505372799 @default.
• W3020242208 hasVolume "1" @default.
• W3020242208 isParatext "false" @default.
• W3020242208 isRetracted "false" @default.
• W3020242208 magId "3020242208" @default.
• W3020242208 workType "article" @default.